MLL2 Mutation Detection in 86 Patients with Kabuki Syndrome: a Genotype-phenotype Study
Overview
Authors
Affiliations
Recently, pathogenic variants in the MLL2 gene were identified as the most common cause of Kabuki (Niikawa-Kuroki) syndrome (MIM#147920). To further elucidate the genotype-phenotype correlation, we studied a large cohort of 86 clinically defined patients with Kabuki syndrome (KS) for mutations in MLL2. All patients were assessed using a standardized phenotype list and all were scored using a newly developed clinical score list for KS (MLL2-Kabuki score 0-10). Sequencing of the full coding region and intron-exon boundaries of MLL2 identified a total of 45 likely pathogenic mutations (52%): 31 nonsense, 10 missense and four splice-site mutations, 34 of which were novel. In five additional patients, novel, i.e. non-dbSNP132 variants of clinically unknown relevance, were identified. Patients with likely pathogenic nonsense or missense MLL2 mutations were usually more severely affected (median 'MLL2-Kabuki score' of 6) as compared to the patients without MLL2 mutations (median 'MLL2-Kabuki score' of 5), a significant difference (p < 0.0014). Several typical facial features such as large dysplastic ears, arched eyebrows with sparse lateral third, blue sclerae, a flat nasal tip with a broad nasal root, and a thin upper and a full lower lip were observed more often in mutation positive patients.
Kabuki and CHARGE syndromes: overlapping symptoms and diagnostic challenges.
Cerqueira B, Milhomem E, Matos A, Pietrobom I, Leprevost C, Heilberg I Einstein (Sao Paulo). 2025; 23:eRC1142.
PMID: 39969027 PMC: 11869784. DOI: 10.31744/einstein_journal/2025RC1142.
Chen L, Li Y, Liu M, Lan Z, Zhang X, Yang X Gen Psychiatr. 2024; 37(5):e101430.
PMID: 39493372 PMC: 11529476. DOI: 10.1136/gpsych-2023-101430.
Genetic and Phenotypic Spectrum of Variants in Taiwanese Case Series of Kabuki Syndrome.
Lee C, Chuang C, Chen M, Lin J, Chiu H, Chang Y Diagnostics (Basel). 2024; 14(16).
PMID: 39202303 PMC: 11353766. DOI: 10.3390/diagnostics14161815.
Clinical and Molecular Characterization of Hyperinsulinism in Kabuki Syndrome.
Rosenfeld E, Mitteer L, Boodhansingh K, Sanders V, McKnight H, De Leon D J Endocr Soc. 2024; 8(7):bvae101.
PMID: 38859884 PMC: 11163021. DOI: 10.1210/jendso/bvae101.
Clinical and molecular characteristics of Korean patients with Kabuki syndrome.
Yoon J, Hwang S, Bae H, Kim D, Seo G, Koh J J Hum Genet. 2024; 69(9):417-423.
PMID: 38824232 DOI: 10.1038/s10038-024-01258-1.